SGLT2 inhibitors versus GLP-1 receptor agonists for major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

ABSTRACT:

SUBMITTER: Ahmed AAO 

PROVIDER: S-EPMC12849425 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature